Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 7 Sept 2026Clinical review pending
!
A previously painless ear can develop a complication
New deep pain, fever, vertigo, facial weakness, postauricular swelling or neurological symptoms in a chronically discharging ear requires a fresh assessment of disease extent.
Action: Arrange urgent ENT assessment, using emergency hospital care for suspected mastoid, labyrinthine or intracranial infection. Do not assume that a long history makes new symptoms harmless.
Synopsis
Evaluate persistent or recurrent discharge through a chronic tympanic perforation, control local infection safely and address hearing loss while excluding destructive middle-ear disease.
Chronic suppurative otitis media involves persistent or recurrent drainage through a longstanding tympanic membrane perforation.
A perforation can also be dry and inactive; it does not require antibiotics merely because a hole remains.
Establish whether discharge comes from middle-ear mucosa, the external canal or a cholesteatoma.
Key red flags
New facial asymmetry, severe vertigo or rapidly worsening hearing can indicate damage beyond the chronically inflamed middle-ear lining.
Investigation priorities
01
Ear swab from active dischargeFirst step
Guide treatment when infection persists or repeatedly returns.
Management branches
Active localized dischargeClean and treat safely
Discharge is consistent with uncomplicated mucosal infection through a chronic perforation.
Inspect adequately, obtain culture where appropriate and arrange trained aural cleaning when debris prevents assessment or drug delivery.
Use a topical preparation selected for the open middle ear under the local ENT or prescribing pathway, explaining any off-label use.
Key medicines
Ciprofloxacin with dexamethasone for selected active CSOMUse an ENT-directed off-label CSOM prescription that specifies the exact preparation, number of drops, frequency and review or stop date. GGC recommends this combination for discharging chronic mucosal disease but does not publish a fixed CSOM course. For formulation reference only, the 3 mg/mL plus 1 mg/mL generic SmPC specifies four drops twice daily for seven days for acute otitis externa; this is not GGC-endorsed CSOM dosing.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.